Pharmaceutical Commerce - June 2019
Your serialization systems aren’t as interoperable as you might think
FDA-accepted pilot projects hope to demonstrate how industry compliance could be realized by the 2023 deadline
New science breakthroughs, and easy access to financing, propel this year’s M&A and licensing market
Will retain position until May 2020
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy
2
Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences
3
Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance
4
Mid-Year Check-In: Has Prior Auth Reform Delivered?
5